The FDA and Feasible Alternative Designs
Drug & Device Law
FEBRUARY 20, 2023
For several decades – starting with plaintiffs’ pre-Vaccine Act attacks on vaccine designs – courts have addressed FDA approval as a component of “feasibility” in states that impose this limitation on design defect claims. Or does it suffice that a vaccine design has been approved in other countries? In Bruesewitz v.
59 
Let's personalize your content